Drug Shortage Report for PROTAMINE SULFATE INJECTION, USP

Last updated on 2021-12-25 History
Report ID 150090
Drug Identification Number 02139537
Brand name PROTAMINE SULFATE INJECTION, USP
Common or Proper name Protamine Sulfate Injection, USP 10 mg/mL SD Vial 5 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) PROTAMINE SULFATE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 mL
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-11-26
Actual start date 2021-11-26
Estimated end date 2021-12-29
Actual end date 2021-12-24
Shortage status Resolved
Updated date 2021-12-25
Company comments We are pleased to advise that our Protamine Sulfate Injection, USP 10 mg/mL SD Vial 25 mL will be available at Ontario distribution centres effective November 30, 2021, and at all other distribution centres by December 2, 2021. The product will be available for substitution during the backorder of the 5 mL.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-12-25 English Compare
v5 2021-12-22 French Compare
v4 2021-12-22 English Compare
v3 2021-11-27 English Compare
v2 2021-11-26 French Compare
v1 2021-11-26 English Compare

Showing 1 to 6 of 6